Diuretics in acute kidney injury

Area of Science:

• Nephrology
• Critical Care Medicine
• Pharmacology

Background:

• Diuretics are commonly used in acute care settings for patients with acute kidney injury (AKI) to maintain urine output.
• The underlying rationale suggests diuretics might protect kidneys from ischemic injury by preventing a non-oliguric state.
• However, evidence regarding diuretic efficacy in improving patient outcomes in AKI remains controversial.

Purpose of the Study:

• To systematically review the literature on the role of diuretics, including osmotic agents, loop diuretics, and nesiritide, in modifying AKI.
• To evaluate the impact of these diuretics on mortality, need for dialysis, renal function recovery, and length of hospital stay.

Main Methods:

• Systematic literature review.
• Evaluation of osmotic diuretics (mannitol), loop diuretics, and nesiritide in the context of AKI.
• Analysis of effects on mortality, dialysis requirements, renal function, and hospitalization duration.

Main Results:

• No evidence supports loop diuretics reducing mortality, dialysis needs, or improving renal function recovery in AKI.
• Mannitol showed no benefit over hydration for rhabdomyolysis and was associated with increased harm and nephropathy.
• Nesiritide did not improve renal function in heart failure patients with mild chronic renal insufficiency but may aid AKI prevention in specific patient groups at lower doses.

Conclusions:

• Diuretics are ineffective in preventing AKI or improving outcomes once AKI has developed.
• The primary benefit of diuretics in AKI appears limited to managing pulmonary edema symptoms due to volume overload.